AVITA Medical, Inc. Reports Q2 2026 Financial Results

What Happened AVITA Medical, Inc. (RCEL) announced its financial results for the quarter ended June 30, 2026 via a press release dated August 6, 2026. The company filed a Current Report on Form 8-K (Aug 6, 2026) that furnishes the press release as Exhibit 99.1. The 8-K was signed by Chief Financial Officer David O’Toole.

Key Details

• Event: Results of Operations and Financial Condition disclosed (Item 2.02) in an 8-K dated August 6, 2026.
• Quarter covered: Quarter ended June 30, 2026.
• Exhibit: Press release is furnished as Exhibit 99.1 (listed under Item 9.01(d)).
• Signature: Form 8-K executed by CFO David O’Toole.

Why It Matters This 8-K signals that AVITA has released its quarterly earnings and related operational results — a primary source for investors to assess recent revenue, profitability, cash position, and any company commentary on trends. The Form 8-K furnishes the press release; investors should review Exhibit 99.1 (the press release) for the specific financial figures, management commentary, and any guidance or next steps, and watch for the company's 10-Q for full financial statements and more detail.